Presentation Information

[27-20-pm06S]Factors influencing plasma disposition of lemborexant and safety assessment in patients with insomnia.

○Inomata Kengo1,2, Asada Kazuhiro3, Shirai Toshihiro3, Masumoto Koki1, Yokoyama Tasuku1, Yazawa Yasuharu1, Kagawa Yoshiyuki1 (1. Sch. Pharm. Sci., Univ. of Shizuoka, 2. Dept. Pharm., Shizuoka Gen. Hosp., 3. Dept. Respir. Med., Shizuoka Gen. Hosp.)